Navigation Links
Drug Firms To Produce Single Pill AIDS Treatment

A single tablet which is taken once a day for treating AIDS is sought to be developed by two drug firms Bristol-Myers Squibb Co and Gilead Sciences Inc. The regimen of three drugs will be contained in the pill, and it is expected to receive a formal approval towards end 2006. //As many as 40 million people across the world are infected by AIDS, with the poor nations accounting for most of the numbers. The US is reported to have 1 million AIDS patients.

The new single pill treatment will also bring in more infected people under its umbrella. The reason for not having brought out a single pill is reported to be purely commercial. Apart from this, no single firm had the rights over all the drugs required to produce a single pill. The three licensed drugs for AIDS will now be combined into a single salmon-colored tablet by the two pharmaceutical firms. The side effects of the drug will not be much while at the same time it will be highly effective. Test lots are already being produced at a manufacturing facility in Ontario.

The only problem with regard to this tablet is ensuring that it has adequate shelf life. If this could be provided at a reasonable price to developing nations, it may well turn out to be a big boon for them. The pill which has not yet been named is targeted to hit the European and the US markets towards end 2006. The three drugs to be combined into a single pill are being marketed under the Emtriva, Viread and Sustiva brand names separately as at present, and account for 20% of the AIDS drugs market. The combined Viread and Emtriva medicines are already in the market under the name of Truvada.
'"/>




Page: 1

Related medicine news :

1. Firms Told To Employ Those With Aspergers Syndrome
2. 12 Chinese Firms Appeal Against Court Ruling On Viagra
3. Drug Firms Meet Annan, Pledge on AIDS Medicines
4. Drug Firms Competing to Produce Cheap and Effective bird flu vaccine
5. US, India Firms Develop New Cure for Black Fever
6. Chemical Firms are Secretly Paying Scientists
7. Supreme Court Seeks Replies From Cola Firms
8. ‘Protein’ Produced By Overstressed Heart Muscle a Strong Indicator Of Heart Diseae
9. Exposure to Pesticides in Schools Produces Illnesses Among Employees, Students
10. World’s First Nerve Stem Cells Produced
11. Chiron Corporation Gets US Contract To Produce Bird Flu Vaccines
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/24/2016)... ... June 24, 2016 , ... Those who have experienced traumatic events ... turn to unhealthy avenues, such as drug or alcohol abuse, as a coping mechanism. ... tools for healthy coping following a traumatic event. , Trauma sufferers tend to feel ...
(Date:6/24/2016)... ... June 24, 2016 , ... Marcy was in a crisis. Her son James, eight, was out ... family verbally and physically. , “When something upset him, he couldn’t control his emotions,” remembers ... would throw rocks at my other children and say he was going to kill them. ...
(Date:6/24/2016)... ... June 24, 2016 , ... Global law firm Greenberg Traurig, P.A. announced that ... chosen by their peers for this recognition are considered among the top 2 percent ... special honors as members of this year’s Legal Elite Hall of Fame: Miami ...
(Date:6/24/2016)... ... 24, 2016 , ... Comfort Keepers® of San Diego, CA is excited to ... Recovery® program to drive cancer patients to and from their cancer treatments. Comfort ... quality of life and ongoing independence. Getting to and from medical treatments is ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... People across ... in Genome magazine’s Code Talker Award, an essay contest in which patients and their ... award to be presented at the 2016 National Society of Genetic Counselors (NSGC) Annual ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... , June 24, 2016   Pulmatrix, Inc ... company developing innovative inhaled drugs, announced today that it ... Russell Investments reconstituted its comprehensive set of U.S. ... "This is an important milestone for Pulmatrix," said ... increase shareholder awareness of our progress in developing drugs ...
(Date:6/23/2016)... -- Research and Markets has announced the addition ... 2022" report to their offering. ... with kidney failure, it replaces the function of kidneys by ... and thus the treatment helps to keep the patient body,s ... Increasing number of ESRD patients & substantial healthcare ...
(Date:6/23/2016)... 23, 2016 Roche (SIX: RO, ROG; OTCQX: ... its Elecsys BRAHMS PCT (procalcitonin) assay as a dedicated ... shock. With this clearance, Roche is the first IVD ... solution for sepsis risk assessment and management. ... and PCT levels in blood can aid clinicians in ...
Breaking Medicine Technology: